Arturo Morales, Ph.D., Joins Analgesic Solutions as Chief Technology Officer

NATICK, Mass., July 6, 2016 /PRNewswire/ -- Analgesic Solutions, a specialty consulting and clinical research company focused on improving the conduct and outcomes of clinical trials in pain, announced today the appointment of Arturo Morales, Ph.D., to the position of Chief Technology Officer. Dr. Morales was most recently Vice President, Technology, Data Science & Corporate Development at Beryllium Discovery, a Bedford, MA-based drug discovery research firm.

Dr. Morales is an accomplished biopharmaceutical executive who will oversee all technical operations at Analgesic Solutions including the ongoing development and commercialization of the Company's proprietary Quantitative Data Surveillance System (QDSS). Upon completing his Ph.D. with Dr. Paul Schimmel at Massachusetts Institute of Technology (MIT), Dr. Morales started his industry career with Genome Therapeutics as a Senior Computational Biologist. He subsequently led a variety of teams at various companies including the Novartis Institutes for Biomedical Research, where he was Global lead for Biology Platform Informatics. Dr. Morales is also the founder of a digital health company that integrates traditional health metrics with a variety of data feeds in order to better identify trends and improve health outcomes. 

"We welcome Dr. Morales to the Analgesic Solutions executive management team, where his fifteen-plus years of experience in data science, information technology, research informatics and computational biology will support our platform expansion and continued growth," said Dr. Nathaniel Katz, Founder, President & Chief Executive Officer of Analgesic Solutions. "The experience and expertise that Dr. Morales brings is especially relevant as we advance our signature QDSS platform, a central statistical surveillance tool used in clinical trial conduct that enables real-time course corrections to ensure optimal data outcomes. Clinical trials in pain are notoriously challenging due to subjectivity and other issues, and QDSS, with its focus on assay sensitivity has the potential to revolutionize the trial process."

Analgesic Solutions, LLC., founded in 2006, is a privately held consulting company and Clinical Research Organization. We are a hands-on team of experts across a variety of disciplines who consult on and conduct clinical trials aimed at bringing important new pain treatments to market. With hundreds of projects completed and ongoing collaborations with regulatory authorities, Analgesic Solutions is the premier choice for providing assistance and training to insure successful pain trials. Clients come to us when looking to develop and commercialize better treatments for pain. Our team, with Nathaniel Katz M.D., M.S., serving as our foremost expert, helps our clients bring their pain solutions to commercial reality.

Logo - http://photos.prnewswire.com/prnh/20160706/386655LOGO

SOURCE Analgesic Solutions